Literature DB >> 30587542

Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.

Meng-Syuan Lin1,2, Po-Yu Liao3, Hui-Mei Chen2, Ching-Pang Chang2, Shih-Kuo Chen4, Yijuang Chern5.   

Abstract

Intrinsically photosensitive retinal ganglion cells (ipRGCs), which express the photopigment melanopsin, are photosensitive neurons in the retina and are essential for non-image-forming functions, circadian photoentrainment, and pupillary light reflexes. Five subtypes of ipRGCs (M1-M5) have been identified in mice. Although ipRGCs are spared in several forms of inherited blindness, they are affected in Alzheimer's disease and aging, which are associated with impaired circadian rhythms. Huntington's disease (HD) is an autosomal neurodegenerative disease caused by the expansion of a CAG repeat in the huntingtin gene. In addition to motor function impairment, HD mice also show impaired circadian rhythms and loss of ipRGC. Here, we found that, in HD mouse models (R6/2 and N171-82Q male mice), the expression of melanopsin was reduced before the onset of motor deficits. The expression of retinal T-box brain 2, a transcription factor essential for ipRGCs, was associated with the survival of ipRGCs. The number of M1 ipRGCs in R6/2 male mice was reduced due to apoptosis, whereas non-M1 ipRGCs were relatively resilient to HD progression. Most importantly, the reduced innervations of M1 ipRGCs, which was assessed by X-gal staining in R6/2-OPN4Lacz/+ male mice, contributed to the diminished light-induced c-fos and vasoactive intestinal peptide in the suprachiasmatic nuclei (SCN), which may explain the impaired circadian photoentrainment in HD mice. Collectively, our results show that M1 ipRGCs were susceptible to the toxicity caused by mutant Huntingtin. The resultant impairment of M1 ipRGCs contributed to the early degeneration of the ipRGC-SCN pathway and disrupted circadian regulation during HD progression.SIGNIFICANCE STATEMENT Circadian disruption is a common nonmotor symptom of Huntington's disease (HD). In addition to the molecular defects in the suprachiasmatic nuclei (SCN), the cause of circadian disruption in HD remains to be further explored. We hypothesized that ipRGCs, by integrating light input to the SCN, participate in the circadian regulation in HD mice. We report early reductions in melanopsin in two mouse models of HD, R6/2, and N171-82Q. Suppression of retinal T-box brain 2, a transcription factor essential for ipRGCs, by mutant Huntingtin might mediate the reduced number of ipRGCs. Importantly, M1 ipRGCs showed higher susceptibility than non-M1 ipRGCs in R6/2 mice. The resultant impairment of M1 ipRGCs contributed to the early degeneration of the ipRGC-SCN pathway and the circadian abnormality during HD progression.
Copyright © 2019 the authors 0270-6474/19/391505-20$15.00/0.

Entities:  

Keywords:  SCN; Tbr2; VIP; circadian disruption; ipRGC; melanopsin

Mesh:

Substances:

Year:  2018        PMID: 30587542      PMCID: PMC6381252          DOI: 10.1523/JNEUROSCI.0571-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  84 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Ideomotor limb apraxia in Huntington's disease: implications for corticostriate involvement.

Authors:  J M Hamilton; K Y Haaland; J C Adair; J Brandt
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

3.  Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.

Authors:  N Ahmad Aziz; Galia V Anguelova; Johan Marinus; Gert Jan Lammers; Raymund A C Roos
Journal:  Parkinsonism Relat Disord       Date:  2010-03-16       Impact factor: 4.891

Review 4.  Axonal spread of neuroinvasive viral infections.

Authors:  Matthew P Taylor; Lynn W Enquist
Journal:  Trends Microbiol       Date:  2015-01-29       Impact factor: 17.079

5.  Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.

Authors:  Chiara La Morgia; Fred N Ross-Cisneros; Alfredo A Sadun; Jens Hannibal; Alessandra Munarini; Vilma Mantovani; Piero Barboni; Gaetano Cantalupo; Kevin R Tozer; Elisa Sancisi; Solange R Salomao; Milton N Moraes; Milton N Moraes-Filho; Steffen Heegaard; Dan Milea; Poul Kjer; Pasquale Montagna; Valerio Carelli
Journal:  Brain       Date:  2010-07-21       Impact factor: 13.501

6.  Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

Authors:  Carlos Cepeda; Raymond S Hurst; Christopher R Calvert; Elizabeth Hernández-Echeagaray; Oanh K Nguyen; Emily Jocoy; Lindsey J Christian; Marjorie A Ariano; Michael S Levine
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Efficient retrograde transport of pseudorabies virus within neurons requires local protein synthesis in axons.

Authors:  Orkide O Koyuncu; David H Perlman; Lynn W Enquist
Journal:  Cell Host Microbe       Date:  2013-01-16       Impact factor: 21.023

8.  Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision.

Authors:  Ali D Güler; Jennifer L Ecker; Gurprit S Lall; Shafiqul Haq; Cara M Altimus; Hsi-Wen Liao; Alun R Barnard; Hugh Cahill; Tudor C Badea; Haiqing Zhao; Mark W Hankins; David M Berson; Robert J Lucas; King-Wai Yau; Samer Hattar
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

9.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

Authors:  G Schilling; M W Becher; A H Sharp; H A Jinnah; K Duan; J A Kotzuk; H H Slunt; T Ratovitski; J K Cooper; N A Jenkins; N G Copeland; D L Price; C A Ross; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

10.  Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease.

Authors:  Koliane Ouk; Steven Hughes; Carina A Pothecary; Stuart N Peirson; A Jennifer Morton
Journal:  Hum Mol Genet       Date:  2016-11-27       Impact factor: 6.150

View more
  6 in total

1.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 3.  Defining circadian disruption in neurodegenerative disorders.

Authors:  Christopher S Colwell
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

Review 4.  A New Perspective on Huntington's Disease: How a Neurological Disorder Influences the Peripheral Tissues.

Authors:  Laura Gómez-Jaramillo; Fátima Cano-Cano; María Del Carmen González-Montelongo; Antonio Campos-Caro; Manuel Aguilar-Diosdado; Ana I Arroba
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

Review 5.  Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

Authors:  Chia-Lung Chuang; Fabio Demontis
Journal:  Ageing Res Rev       Date:  2021-05-09       Impact factor: 11.788

6.  Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.

Authors:  Koliane Ouk; Juliet Aungier; Michelle Ware; A Jennifer Morton
Journal:  eNeuro       Date:  2019-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.